Phase II Study Evaluating Toxicity and Efficacy of Lenalidomide (Revlimid®) in Chemotherapy-Naïve Androgen Independent Prostate Cancer Patients

This study is currently recruiting participants.
Information provided by Oncology Specialists, S.C.

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Prostate Cancer
2		Additional conditions recognized in this trial
			Prostatic Neoplasms
3		More general conditions related to this trial
			Genital Diseases, Male
			Genital Neoplasms, Male
			Neoplasms
			Neoplasms by Site
			Prostatic Diseases
			Urogenital Neoplasms
4		Interventions listed in this trial
			Revlimid
5		Additional drug interventions recognized in this trial
			Lenalidomide
6		More general drug interventions related to this trial
			Antineoplastic Agents
			Pharmacologic Actions
			Therapeutic Uses
7		Sponsors listed in this trial
			Oncology Specialists, S.C.
			Celgene Corporation